Discover
CSBR
Champions Oncology, Inc.
5.19
2 x 5.27
37 x 5.30
bid
ask
+
0.00
0.00%
1 @ 04:00 PM
5.19 +0.00 (0.00%)
| Ytd | -24.89% | |
| 1y | -15.06% |
5.00
day range
5.27
5.19
52 week range
8.30
| Open | 5.00 | Prev Close | 5.19 | Low | 5.00 | High | 5.27 | Mkt Cap | 72.11M |
| Vol | 4.28K | Avg Vol | 9.09K | EPS | -0.16 | P/E | -32.44 | Forward P/E | 42.68 |
| Beta | 0.49 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 03-12 | 50-d Avg | 5.98 | 200-d Avg | 6.29 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 13.84M | ||
| Revenues (USD) | 13.84M | ||
| Cost of Revenue | 6.81M | ||
| Gross Profit | 7.03M | ||
| Operating Expenses | 7.55M | ||
| Research and Development Expense | 2.12M | ||
| Selling, General and Administrative Expense | 5.43M | ||
| Operating Income | -522.00K | ||
| Income Tax Expense | 172.00K | ||
| Net Income | -667.00K | ||
| Net Income Common Stock | -667.00K | ||
| Net Income Common Stock (USD) | -667.00K | ||
| Consolidated Income | -667.00K | ||
| Earnings per Basic Share | -0.04 | ||
| Earnings per Basic Share (USD) | -0.04 | ||
| Earnings per Diluted Share | -0.04 | ||
| Earning Before Interest & Taxes (EBIT) | -495.00K | ||
| Earning Before Interest & Taxes (USD) | -495.00K | ||
| Weighted Average Shares | 13.91M | ||
| Weighted Average Shares Diluted | 13.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.87M | ||
| Cash and Equivalents (USD) | 4.87M | ||
| Trade and Non-Trade Receivables | 13.18M | ||
| Current Assets | 19.22M | ||
| Property, Plant & Equipment Net | 7.22M | ||
| Total Assets | 26.99M | ||
| Debt Current | 1.52M | ||
| Total Debt | 4.51M | ||
| Current Liabilities | 19.92M | ||
| Debt Non-Current | 2.99M | ||
| Total Liabilities | 22.92M | ||
| Accumulated Retained Earnings (Deficit) | -81.07M | ||
| Shareholders Equity | 3.94M | ||
| Shareholders Equity (USD) | 3.94M | ||
| Assets Non-Current | 7.77M | ||
| Total Debt (USD) | 4.51M | ||
| Deferred Revenue | 8.83M | ||
| Goodwill and Intangible Assets | 335.00K | ||
| Liabilities Non-Current | 3.00M | ||
| Trade and Non-Trade Payables | 6.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 321.00K | ||
| Net Cash Flow from Financing | -19.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.25M | ||
| Capital Expenditure | -238.00K | ||
| Issuance (Repayment) of Debt Securities | -19.00K | ||
| Net Cash Flow from Investing | -238.00K | ||
| Net Cash Flow from Operations | -2.00M | ||
| Share Based Compensation | 357.00K | ||